Casimir Jones, S.C.
Therapeutic agent for cancer which comprises combination of IL-18 and molecule-targeting antibody
A cancer therapeutic agent according to an embodiment of the present invention contains, as active ingredients, IL-18 and one or more antibodies selected from the group consisting of an anti-PD-L1 antibody, an anti-PD-1 antibody, an anti-PD-L2 antibody, an anti-CTLA-4 antibody, an anti-CD25 antibody, an anti-CD33 antibody, and an anti-CD52 antibody.
Foundation for Biomedical Research and Innovation Medical Research and Development Corporation
A C A C A A A A A A A A A A
A61P C07K A61K C07K A61K A61K A61P A61P A61K A61K A61P A61P A61P A61P
inventional inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Haruki Kyosuke Wen
Okamura Yamanishi Li